ANI Pharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has ANI Pharmaceuticals's balance sheet done over the years? Its assets were worth $904,422,000 last year, which is more than in the previous period. 49% of ANI Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $446,823,000, which means an increase by 6% compared compared to last year.
Debt to Assets
| 2014 | 263709000 | 123.92M | 46.99% |
|---|---|---|---|
| 2015 | 285265000 | 125.18M | 43.88% |
| 2016 | 322864000 | 153.21M | 47.46% |
| 2017 | 412138000 | 237.38M | 57.6% |
| 2018 | 430604000 | 233.34M | 54.19% |
| 2019 | 456789000 | 243.99M | 53.42% |
| 2020 | 461190000 | 265.49M | 57.57% |
| 2021 | 771598000 | 412.85M | 53.51% |
| 2022 | 760087000 | 421.54M | 55.46% |
| 2023 | 904422000 | 446.82M | 49.4% |
ANIP Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 221.12M | 48.22M | 100.3M | 7.86M | 62.33M | 43.00M | 31.14M | 27.36M | 154.68M | 169.03M |
Short term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net receivables | 162.07M | 165.43M | 128.52M | 95.79M | 72.12M | 64.84M | 58.78M | 45.89M | 21.93M | 17.29M |
Inventory | 111.19M | 105.35M | 81.69M | 60.80M | 48.16M | 40.50M | 37.72M | 26.18M | 13.38M | 7.51M |
Other current assets | 25.42M | 8.38M | 11.25M | 5.86M | 5.07M | 4.52M | 3.94M | 3.56M | 2.58M | 10.76M |
Total current assets | 519.81M | 344.26M | 321.77M | 170.32M | 187.69M | 152.87M | 131.60M | 103.00M | 192.58M | 203.47M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 44.59M | 43.24M | 52.67M | 41.26M | 40.55M | 38.09M | 20.40M | 10.99M | 7.13M | 5.22M |
Goodwill | 28.22M | 28.22M | 27.88M | 3.58M | 3.58M | 3.58M | 1.83M | 1.83M | 1.83M | 1.83M |
Intangible assets | 209.00M | 251.63M | 294.12M | 188.51M | 180.38M | 201.60M | 229.79M | 175.79M | 66.39M | 42.06M |
Long term investments | 0 | 8.75M | 5.00M | 5.00M | 5.02M | 5.02M | 800K | 5.00M | -17.31M | 0 |
Other non-current assets | 12.07M | 2.60M | 2.20M | 802K | 1.22M | 1.46M | 5.03M | 0 | 17.31M | 3.30M |
Total non-current assets | 384.60M | 415.82M | 449.82M | 290.86M | 269.09M | 277.72M | 280.53M | 219.85M | 92.68M | 60.23M |
Total assets | 904.42M | 760.08M | 771.59M | 461.19M | 456.78M | 430.60M | 412.13M | 322.86M | 285.26M | 263.70M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 0 | 87K | 80K | 451K | 711K | 23.97M | 0 | 0 | 0 |
Short term debt | 2.41M | 850K | 850K | 13.24M | 9.94M | 115.71M | 3.35M | 0 | 0 | 0 |
Total current liabilities | 145.47M | 99.43M | 87.53M | 78.56M | 61.67M | 165.54M | 39.22M | 31.94M | 11.75M | 13.23M |
| Non-current liabilities: | ||||||||||
Long term debt | 284.81M | 285.66M | 286.52M | 172.44M | 175.80M | 67.29M | 198.15M | 120.64M | 113.42M | 110.69M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 16.52M | -44.92M | 38.80M | 14.48M | 6.51M | 496K | 0 | 625K | 0 | 0 |
Total non-current liabilities | 301.34M | 322.10M | 325.32M | 186.92M | 182.32M | 67.79M | 198.15M | 121.26M | 113.42M | 110.69M |
Total liabilities | 446.82M | 421.54M | 412.85M | 265.49M | 243.99M | 233.34M | 237.38M | 153.21M | 125.18M | 123.92M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |